Abstract
Over the last two decades proteins have become increasingly important in human therapy and diagnosis. Engineering therapeutic proteins through improving their biological activity and stability has been a major interest in our group. In this mini-review we summarize our research on three proteins with pharmaceutical potential – serine protease inhibitor from squash seeds (CMTI), bovine pancreatic trypsin inhibitor (BPTI), and human fibroblast growth factor 1 (FGF1). To improve the functional properties of these proteins we used multiple techniques such as homology approach, rational design, total chemical synthesis, site-directed mutagenesis and phage display. The physicochemical properties of the obtained protein variants were evaluated using protein crystallography, spectroscopic techniques, enzymatic assays, stability measurements as well as numerous biological tests.
Keywords: Protein engineering, protein therapeutics, protease inhibitors, squash inhibitors, BPTI, FGF1, protein stability, human therapy and diagnosis, homology approach, numerous biological tests, Hageman factor, pharmacological properties, antimicrobial peptides, heparan sulfate proteoglycans (HSPGs), heparans (HS)
Current Pharmaceutical Biotechnology
Title: Tailoring Small Proteins Towards Biomedical Applications
Volume: 12 Issue: 11
Author(s): Malgorzata Zakrzewska, Anna Szlachcic and Jacek Otlewski
Affiliation:
Keywords: Protein engineering, protein therapeutics, protease inhibitors, squash inhibitors, BPTI, FGF1, protein stability, human therapy and diagnosis, homology approach, numerous biological tests, Hageman factor, pharmacological properties, antimicrobial peptides, heparan sulfate proteoglycans (HSPGs), heparans (HS)
Abstract: Over the last two decades proteins have become increasingly important in human therapy and diagnosis. Engineering therapeutic proteins through improving their biological activity and stability has been a major interest in our group. In this mini-review we summarize our research on three proteins with pharmaceutical potential – serine protease inhibitor from squash seeds (CMTI), bovine pancreatic trypsin inhibitor (BPTI), and human fibroblast growth factor 1 (FGF1). To improve the functional properties of these proteins we used multiple techniques such as homology approach, rational design, total chemical synthesis, site-directed mutagenesis and phage display. The physicochemical properties of the obtained protein variants were evaluated using protein crystallography, spectroscopic techniques, enzymatic assays, stability measurements as well as numerous biological tests.
Export Options
About this article
Cite this article as:
Zakrzewska Malgorzata, Szlachcic Anna and Otlewski Jacek, Tailoring Small Proteins Towards Biomedical Applications, Current Pharmaceutical Biotechnology 2011; 12 (11) . https://dx.doi.org/10.2174/138920111798376905
DOI https://dx.doi.org/10.2174/138920111798376905 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Modified Cell Transplantation for Vascular Regeneration
Current Gene Therapy Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease
Current Medicinal Chemistry Association of Zinc and Copper Status with Cardiovascular Diseases and their Assessment Methods: A Review Study
Mini-Reviews in Medicinal Chemistry Carbohydrates in Therapeutics
Cardiovascular & Hematological Agents in Medicinal Chemistry Pancreas Development and β-Cell Differentiation of Embryonic Stem Cells
Current Medicinal Chemistry Validation of the Neuroinflammation Cycle as a Drug Discovery Target Using Integrative Chemical Biology and Lead Compound Development with an Alzheimers Disease-Related Mouse Model
Current Alzheimer Research Triterpenoids for Cancer Prevention and Treatment: Current Status and Future Prospects
Current Pharmaceutical Biotechnology Knowledge, Attitude and Practice of the use of Nanoparticles in the Treatment of Oral Cancer Patients
New Emirates Medical Journal Chinese Herbal Formulas and Renal Fibrosis: An Overview
Current Pharmaceutical Design Computational Drug Design Targeting Protein-Protein Interactions
Current Pharmaceutical Design (Section B: Integrated Function of Drug Transporters In Vivo) Drug Transport at the Blood-Brain Barrier and the Choroid Plexus
Current Drug Metabolism Pharmacological Strategies for COVID-19 - A Review of the Most Promising Repurposed Antiviral Drugs
Infectious Disorders - Drug Targets NOX3-Targeted Therapies for Inner Ear Pathologies
Current Pharmaceutical Design Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies
Current Pharmaceutical Design Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations
Current Medicinal Chemistry Toll-like Receptor 4 Mediates LPS-Induced Release of Nitric Oxide and Tumor Necrosis Factor-α by Embryonal Cardiomyocytes: Biological Significance and Clinical Implications in Human Pathology
Current Pharmaceutical Design Ethosomes and its Applications in Transdermal Drug Delivery
Current Drug Therapy Editorial [Hot Topic: Nanotechnology Enables Superior Medical Therapies (Guest Editors: Marianna Foldvari & Mahmoud Elsabahy)]
Current Drug Delivery Neuronal Membranes are Key to the Pathogenesis of Alzheimers Disease: the Role of Both Raft and Non-Raft Membrane Domains
Current Alzheimer Research